Raben David
SEC insider (Form 3/4/5 filer). CIK 0002034679. Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX) and 1 other issuer. 19 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Raben David has filed insider reports for
- PLIANT THERAPEUTICS, INC. (PLRX): Officer, Chief Medical Officer
- Bicara Therapeutics Inc. (BCAX): Officer, Chief Medical Officer
Raben David
CIK: 0002034679
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Oct 1, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
575K shares- - Apr 27, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect5.5K shares at avg. $22.88$126K - Apr 27, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect5.5K shares at avg. $3.79$21K - Mar 25, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect5.5K shares at avg. $18.95$104K - Mar 25, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect5.5K shares at avg. $3.79$21K - Mar 4, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect16.3K shares at avg. $3.79$62K - Mar 4, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect16.3K shares at avg. $18.52$302K - Mar 3, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect200 shares at avg. $3.79$757.96 - Mar 3, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect200 shares at avg. $18.45$4K - Feb 2, 2026BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 575,000 | - | - | Direct |
| Apr 27, 2026 |  BCAX Bicara Therapeutics Inc. | Sale | 5,500 | $22.88 | $125,830 | Direct |
| Apr 27, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 5,500 | $3.79 | $20,844 | Direct |
| Mar 25, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 5,500 | $18.95 | $104,229 | Direct |
| Mar 25, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 5,500 | $3.79 | $20,844 | Direct |
| Mar 4, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 16,300 | $3.79 | $61,774 | Direct |
| Mar 4, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 16,300 | $18.52 | $301,920 | Direct |
| Mar 3, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 200 | $3.79 | $758 | Direct |
| Mar 3, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 200 | $18.45 | $3,690 | Direct |
| Feb 2, 2026 | BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
1-10 of 19 transactions